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Abstract

EXPLORING THE USE OF PIOX SYSTEM FOR TREATMENT OF ENDOCRINE
DISRUPTING COMPOUNDS
Alexander Pearson
Thesis Chair: Torey Nalbone, Ph.D.
The University of Texas at Tyler
November 2020

In this thesis, the Photon Initiated Oxidation (PIOx) system was investigated for its possible
use in the treatment of Endocrine Disrupting Compounds (EDCs). It was theorized that the
unique design of the system, namely the multiple wavelengths of UV light and the
micronfoam would improve removal rates of the test contaminant when compared to other
systems. 17β-estradiol was chosen as the test contaminant due to the compounds known
sensitivity to ozone exposure. Two methods of testing were used, the first to test an idealized
homogenous concentration (method one) and the second to mimic the sudden influx of
contaminant that would be common in a water and wastewater treatment environment
(method two). Method one showed degradation to below level of detection within 15
minutes. Method two showed a reduction trend but with 60-80% eliminated by the end of 15
minutes. While the PIOx system did not perform above expectations, its simplicity and
compact form-factor allows the system to be applicable in a significant number of situations
where other AOPs would be too expensive or complex to implement. Continued research is
required into the PIOx systems capabilities and its application to low budget and rural
environments.
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Chapter 1
Introduction and General Information
Overview
Over the last several decades, mankind has made use of many natural and synthetic
compounds as a part of human industry, agriculture, and general activity. Of the tens of
thousands of chemical compounds and products, approximately 1000 are recognized and
studied as possible endocrine disrupting chemicals (EDCs). An EDC can be more
rigorously defined as “an exogenous chemical, or mixture of chemicals, that can interfere
with any aspect of hormone action” (Zoeller et al., 2012, p. 4107).

Figure 1.1: How EDCs affect hormonal action (Endocrine Disruptors, 2020)

They can interfere with normal hormonal actions in the body in two general ways as
shown in Figure 1.1, either by changing the production of hormones either positively or
negatively, by mimicking the structure of hormones so it activates the same receptors as
the body’s natural hormones, or by blocking the receptors and preventing natural
1

processes. Because of their ability to affect such a key part of the body’s chemistry, many
of these chemicals have the capacity for doing harm to both humans and wildlife. Even
though immediate harm is unlikely at current ecological concentrations, concentrations in
the parts per billion (ppb) to parts per trillion (ppt) range, organisms that are exposed at
vulnerable time periods such as during or just after pregnancy, or during infancy are at
risk of significant illnesses, deformities, and future reproductive problems (Street et al.,
2018, p. 1647) .
History
EDCs, which are also referred to as hormonally active agents, endocrine active
substances, chemicals of emerging concern, or micropollutants, are a growing matter of
concern for a wide swath of the scientific field. They have been found to be a consistent
part of our environment due to many human activities, which includes agricultural,
industrial, and municipal sources. This constant background exposure has been identified
within the last several decades due to the effects EDCs were having on the wildlife in
heavily impacted ecosystems and from cross disciplinary discoveries.

During the 1960s and 1970s when the public and the scientific community were first
starting to realize the possible ramifications of manufactured chemicals on the
environment, a number of ecological and environmental studies were being carried out by
independent researchers. Several worrying patterns were emerging. In the North
American Great Lakes, fish, reptiles, and birds were emerging with reproductive and
developmental abnormalities including thinned egg shells, increased number of in-egg
2

deaths, hermaphroditic characteristics (i.e. displaying both masculine and feminine sexual
organs), increasing number of abnormal, malfunctioning, or disable genitalia leading to
population declines (Street et al., 2018, p. 1647). Studies in Florida showed similar
reproductive deformities in alligators and turtles, leading to similar die-offs. Meanwhile,
in England, fish were studied that showed similar reproductive anomalies: testes holding
eggs and males displaying an egg protein formed due to presence of estrogen (Schug et
al., 2016, p. 844). It was clear that these were not isolated incidents but symptoms of a
growing global problem.

In the mid-90s, the United States Environmental Protection Agency (US EPA) conducted
2 international meetings to gather people together for information sharing and to
determine research needs. Due to this meeting and several others like it in Europe, many
regulations and policies were put in to place to limit EDC exposure. In America, the EPA
was directed to assess the hormonal impact of more than 70,000 known compounds
which lead to developing a 3-tiered endocrine disruptor screening program testing the
estrogen, androgen, and thyroid axis (Schug et al., 2016, p. 844). This program is
continuing to grow and be used to this day. In 1968 Japan, a large amount of oil was
contaminated with polychlorinated biphenyls (PCBs), a group of industrial compounds
used as plasticizers, pigments, and in electrical insulation and heat transfer, leading to
thousands of sick people. Later research showed that the exposure had longer term
consequences with women that were exposed being more likely to have children with low
birth weight and slower neurological development. Due to these events, Japan became
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one of the first nations to have a national response to the EDC problem by starting
initiatives focused on environmental monitoring and sponsoring several more
International meetings discussing EDCs from 1998 to 2007 (Schug et al., 2016, p. 844).
In Europe, multiple workshops on the impact of endocrine disruptors on human health
and wildlife led to a substantial increase in research funding by the European Union into
the effects of EDCs on wildlife and humans as well as their mechanisms of action. These
actions culminated in a report in 2012 summarizing the last 15 years of research which
reinforces the seriousness of the situation by calling endocrine disruptors “a real
phenomenon likely affecting both human and wildlife populations globally.”
Exposure, Standard Treatment, & Risk
As the international community becomes more cognizant of the effects EDCs have on the
environment, monitoring of many EDCs have become more widespread despite how low
the environmental concentrations are. While they can be released into the atmosphere via
combustion, the primary areas of accumulation are in ground water, rivers, and lakes, all
key sources for drinking water (Auriol et al., 2006, p. 538). Drinking water supplies
across the world have been observed with EDC concentrations from 0.2 ng/L to 5510
ng/L (Lee et al., 2016, p. 184; Rosa Boleda et al., 2011, p. 1605; Wee & Aris, 2017, p.
224; Yang et al., 2014, p. 57). The mechanisms for contamination are the same for EDCs
as they are for any other kind of contaminant, through storm water runoff sweeping
chemicals into the water stream, leeching into the ground water, or by just being sent to
the wastewater treatment plant. The difference is this contamination can come from a
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variety of sources as EDCs are used in a large number of products, like plastics,
cosmetics, pharmaceuticals, pesticides, and even just natural hormones.
Figure 1.2: Means of exposure to EDCs in drinking water (Wee & Aris, 2019, p. 1)

5

For mature adult humans the damage in the short term is negligible but that doesn’t mean
there aren’t affects. EDCs have been observed in bodily fluids like breast milk, blood,
sweat, and urine (Jönsson et al., 2014, p. 5). Over an entire lifetime, a person will be
exposed to a pharmaceutical level of exposure through consumption of drinking water,
which equates to <10% of a daily medical dose (Houtman et al., 2014, p. 55). Infants,
who are significantly more susceptible to the effects of EDCs, have a significantly higher
average level of exposure, 1340 ng/day compared to an adults 148 ng/day, of bisphenol A
(BPA), an EDC that leaches out of the plastic baby bottles (Leung et al., 2013, p. 845).

One of the possible reasons for the somewhat sluggish regulatory response to EDCs is the
difficulty in accurately assessing the risk involved in their exposure. Risk assessment
(RA) is a process for identifying risk factors related to a potentially hazardous action or
situation, evaluate the risk associated with the hazard, and finally determine means to
either eliminate the hazard or minimize the risk associated with the hazard (OSH Answers
Fact Sheets, 2020). The previously mentioned data point illustrates two of the problems
that have made RA for EDCs difficult. It shows the difficulty in assessing possible
exposure, as there is consistent background exposure due to EDCs suffusing the
environment and that slight changes to the situation can wildly change the level of
exposure. Other issues that have gotten in the way of assessing exposure include the
importance of timing, which can drastically change the effect of EDC exposure, and the
impact of transgenerational effects from multiple generations of EDC exposure (Futran
Fuhrman et al., 2015, p. 607). There is lack of data surrounding chronic exposure in
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humans in addition to a steadily growing list of compounds that have been labeled an
EDC and need to be researched. In addition, there is little research into the effect of
simultaneous exposure to several different EDCs which may have hormonal actions that
interfere with each other in unpredictable manners. Finally, the lack of a unified
definition as to what an EDC even is makes discussion of the hazards associated with
them difficult. While the definition of “exogenous agent that interferes with the synthesis,
secretion, transport, binding, action, or elimination of natural hormones in the body that
are responsible for the maintenance of homeostasis, reproduction, development, and/or
behavior,” seems to be an effective working answer for what an EDC is, it fails to address
the “quality of interference” by omitting reference to any adverse effects. This leads to
EDC being a larger more blanket term that covers more edge cases but also makes the
situation vague when decisiveness is needed. Overall, the emergence of EDCs has caused
RA to have to adapt due to their broad scope and defiance of standard assessment
methods.

The problem is that current treatment practices, both for drinking water and wastewater,
are not capable of completely removing EDCs from the water stream as shown in Table
1.1. While the removal efficacy is high for all the measure compounds in Table 1.1, the
concentrations that remain are still within the range shown to have negative health effects
and endocrine disruption in aquatic organisms (Auriol et al., 2006, p. 532). In addition,
there really is no consensus on the mechanism of removal for many of the compounds in
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the case of standard treatment. This makes improving the existing system to deal with the
remaining contaminants difficult if not impossible.

Table 1.1: EDC concentrations and removal efficiency for standard treatment processes
Compound

Removal
Treatment
efficacy
Matrice type
process
(%)

Concentration
Influent

Effluent

5 ng/L

<1 ng/L

>80

1

Municipal waste
landfill

11 ng/L

1.6 ng/L

86

2

Municipal STP

9.69 ng/L

4 ng/L

59

2

Domestic STP

28.1 ng/L

1.2 ng/L

96

2

Domestic STP

–

–

100

2

Municipal STP

44 ng/L

17 ng/L

61

2

Municipal STP

31 ng/L

24 ng/L

23

2

Domestic STP

43.1 ng/L

12.3 ng/L

69

2

Domestic STP

–

–

83

2

Municipal STP

72 ng/L

2.3 ng/L

97

2

Municipal STP

57.29 ng/L

11.71 ng/L

80

2

Domestic STP

381.5 ng/L

5.6 ng/L

99

2

Domestic STP

1.40 ng/L

71

2

Domestic STP

–

–

78

2

Municipal STP

Phenol

6 mg/L

No detected

–

3

Municipal + tannery
industry STP

Nitrophenol

11 mg/L

No detected

–

3

Municipal + tannery
industry STP

16 mg/L

81

3

Municipal + tannery
industry STP

17β-Estradiol

Estrone

Estriol

17α4.84 ng/L
Ethinylestradiol

2,483 mg/L
Dichlorophenol
NP1EO

140.03 mg/L 1.99 mg/L

99

4

Industrial + domestic
STP

NP2EO

140.03 mg/L 1.99 mg/L

99

4

Industrial + domestic
STP

8

Compound

Removal
Treatment
efficacy
Matrice type
process
(%)

Concentration
Influent

Effluent

2.8 mg/L

<0.05 mg/L

>98

1

Municipal waste
landfill

1.5 mg/L

6.6 mg/L

–

3

Municipal + tannery
industry STP

57.64 mg/L

0.65 mg/L

99

4

Industrial + domestic
STP

10 mg/L

1 mg/L

90

2

Domestic STP

73 mg/L

47.5 mg/L

35

5

Industrial STP

4-NP

2.37 mg/L

0.95 mg/L

60

6

Municipal STP

4-t-OP

0.88 mg/L

0.32 mg/L

64

6

Municipal STP

PCBs

46 ng/L

1.2 ng/L

97

1

Municipal waste
landfill

BPA

0.13 mg/L

<0.005 mg/L >96

1

Municipal waste
landfill

7.1 mg/L

No detected

–

3

Municipal + tannery
industry STP

2.5 mg/L

No detected

–

3

Municipal STP

1.776 mg/L

0.210 mg/L

88

6

Municipal STP

0.55 mg/L

0.14 mg/L

75

2

Domestic STP

PCDD

21 pg/L

5.2 pg/L

75

1

Municipal waste
landfill

PCDF

8.7 pg/L

3.3 pg/L

62

1

Municipal waste
landfill

NP

Health Effects in Animals
As technology advanced more EDCs were identified and animal laboratory studies began
to be conducted. These studies on EDC exposure in mice and rats showed exposure, even
at extremely low concentrations, had noticeable effects, both physical and behavioral
(Street et al., 2018, p. 1647). These behavioral changes include increased anxiety like
9

behaviors, impairment of spatial learning and memory, and reduction of maternal
behavior. In addition, there appeared to be an epigenetic aspect to the morphological
changes, a change in genome of an individual due to environmental factors that can be
inherited. This transgenerational inheritance is a point of worry and concern in the
scientific community as it seems to be supported by the studies on exposure in humans.
Health Effects in Humans
Studies into the effect general low-level EDC exposure has on human health is less
certain due to the constant exposure from the environment, however there are still
connections that can be drawn. EDCs have been connected to reproductive illnesses in
humans, including testicular, breast, ovarian, cervical, and uterine cancers, and infertility
(Mallozzi et al., 2017, p. 334; Prins, 2008, p. 653; Rachoń, 2015, p. 360). In addition,
there is evidence that exposure to EDCs may lead to obesity, insulin resistance, attention
deficit hyperactivity disorder (ADHD), autism and other neurodevelopmental diseases.

Although there is a sizable body of work connecting EDCs to illnesses, disorders,
abnormalities, and other negative health effects, there is not a solid consensus on what
health risk EDCs pose to humans. Most EDCs are not recognized as a treatment goal for
water and wastewater treatments, though that is changing. Experimental solutions for
removing or degrading the EDCs as a tertiary treatment option are being explored for
water and wastewater treatment plants. There are a few general categories that these
solutions fit into. They are removal by physical means, such as using carbon filters or
membranes, by biodegradation, similar to an extension of current wastewater practices,
10

and by chemical advanced oxidation, which typically involves using an oxidizer and
sometimes UV light to eliminate contaminants. This final category includes the Photon
Initiated Oxidation (PIOx) system which is the focus of this paper.
The PIOx System
The PIOx system was originally put together as a means of sanitizing wash water for
reuse in dairy plants and similar businesses. The system has several key features that it
uses to accomplish this. It contains high intensity UV bulbs that primarily output at
several wavelengths as shown in Figure 1.x to serve two functions, a wavelength of 185
nanometers to create ozone from the air and a wavelength of 254 nanometers to sterilize.

As it will be shown in detail in chapter 2, the addition of UV radiation to the ozone
oxidation reaction increases the efficiency significantly. This introduces a dilemma of
some consequence; where do you source the ozone from. UV light can form ozone by
reacting with oxygen and water. However, UV bulbs that are most efficient for
synthesizing ozone, which includes the bulbs used in the PIOx system, are the least
capable of directly oxidizing organic compounds. They output at too narrow of a
wavelength range to be widely effective against most organic compounds. Conversely,
radiation sources of a sufficiently broad spectrum to be effective at oxidizing organic
compounds makes ozone generation difficult.

11

Figure 1.3: Wavelength distribution for PIOx UV lamps

The bulbs used in this system are low pressure vacuum UV lamps with a lamp input of
100 W, with 9 W of radiation at 185 nm. Around the UV lamps is a metal sleeve drilled
with 2 micrometer wide holes. The water is pumped past the lamps inside the metal
sleeve while an air pump creates a pressure buildup of around 1-2 pounds per square inch
(psi). This positive pressure creates a foam that increases surface area which would aid in
increasing ozone contact in the water. The similarity of this system to current attempted
solutions and the addition of a micron as a new variable is what lead to this exploration of
the PIOx system.

The PIOx system used for this project was assembled by myself and an undergraduate
who was performing experiments for a research project that ran parallel to my own. The
frame and the tank had already been delivered to the university along with the bulbs and
12

the housing for the bulbs. In order to complete the structure, we had to obtain a water
pump, an air pump, nonreactive tubing for the ozone, tubing for the water pump, an
electrical panel box, conduit, and a high voltage electrical connection. Assembling the
system took place over several months due to waiting for parts, troubleshooting electrical
components and issues, and the unfortunate need to reorder the mercury bulbs after the
apparatus was inadvertently moved, breaking the bulbs.
Figure 1.4: Diagram of PIOx use of air pressure

17β-Estradiol
The EDC that was chosen to be the target contaminant in this thesis is 17β-Estradiol,
which is typically abbreviated as E2. 17β-Estradiol is a steroidal estrogen hormone that is
produced mainly in the ovaries, in the placenta during pregnancy, and in very low
concentrations in the testis. It is a key hormone in the regulation of the menstrual cycle
and in the expression of secondary sex characteristics (Rexroad, 1977, p. 86). It also
13

impacts bone growth, brain development and maturation, and concentrations of calcium
and some messenger molecules between cells. It is a part of the estrogen group of
compounds, which includes estradiol, estrone, and estriol of which estradiol is the most
concentrated and the most active (The Serotonin Molecule, 2006).
Figure 1.5: Estradiol molecular structure

Estradiol is also used for medical purposes including birth control and hormone
replacement therapy (HRT) to treat symptoms of post-menopause. However, it has also
been connected to an increased risk of stroke and breast cancer (Huang et al., 2007, p.
148) in addition to several lifestyle diseases such as hypertension, reproductive and
metabolic disorders (Gore et al., 2015). Estradiol is also tentatively linked to several
neurological disorders as well as several behavioral disorders (MohanKumar et al., 2018).
Studies have also shown that exposure to estradiol during prepubescence can lead to
excessive rapid growth, delayed puberty in males and early puberty in females (U.S.
Department of Health and Human Services, 2007). These health risks have led to
increasing interest in minimizing contact with estradiol and finding methods for
eliminating it from water streams and other means of exposure.

14

Estradiol is quite stable due to its four linked carbon rings. Three of the rings are single
bonded while the last ring shows phenolic properties. 17β-Estradiol bears structural
similarity with the other estrogen molecules, all of which have the same carbon ring
skeleton and the phenolic ring which is quite sensitive to ozone exposure.

In order to eliminate the estrogenic activity of estradiol, the carbon rings that make up the
majority of its structure would need to be ruptured through chemical reactions which will
be discussed further in later sections. If that could be accomplished, then the estrogenic
impact could be reduced if not eliminated. This elimination of estrogenic activity is
corroborated by research into the byproducts of E2 oxidation and their estrogenic toxicity
(source). After exposing E2 to advanced oxidation processes, the byproducts were
examined using a mass spectrometer to identify the individual steps of the degradation
pathways. When those intermediate compounds were examined using various assays and
simulations, the compounds whose phenolic group was broken showed little to no
estrogenic activity while the those with intact phenolic groups still displayed toxic
effects.

15

Figure 1.6: Simplified pathway for photodegradation of E2

Figure 1.7: predicted chronic and acute ecotoxicity of E2 and byproducts

Ozone Oxidation and Decomposition
Ozone exposure has two pathways for oxidizing organic compounds. The direct pathway,
where the molecular ozone is what affects the contaminant compounds, is the main
reaction in acidic conditions or when certain compounds inhibit the decomposition of

16

ozone. The radical pathway, so named by the hydroxyl radicals and other secondary
oxidants that are produced by ozone decomposition, is the main reaction under basic
conditions or when certain compounds promote ozone decomposition which increases the
chain reaction.
Figure 1.6: Ozone and dissolved solids reaction (Ozone Reaction Mechanisms, 2003)

Research from Staehelin and Hoigne (1985, p. 1211) outlined a general model for these
reaction pathways. In an aqueous ozonated solution, the ozone is either consumed
reacting with a contaminant, become an ozonide ion radical (·O 3-) by electron transfer, or
start decomposing. The decomposition reaction is initiated by a hydroxide ion (OH -)
reacting with an ozone molecule which forms one super oxide anion (·O 2-) and one
hydroperoxyl radical (HO2·) in an acid-base equilibrium (pKa=4.8). The HO2· can further
dissociate into a hydrogen ion (H+) and another ·O2-.

𝑂 + 𝑂𝐻 → 𝑂 ∙ + HO ∙
𝐻𝑂 ·↔ H + · O
The ·O2- can further react with ozone molecules through electron transfer to form ·O 3-.

17

O +O

−→

O

−

+O

The next step in the decomposition model is propagation. The ·O 3- reacts with H+, called
protonation, before decomposing into ·OH radicals. These radicals can then react with
any contaminants in the solution. Some compounds, known as promoters, that the ·OH
radicals can react to give off ·O2- as a part of the reaction which can continue the chain
reaction. Many other compounds that do react with ·OH radicals do not produce
HO2·/·O2- and because of this typically terminate the chain reaction. These compounds
are called radical catchers or inhibitors and include, formic acid, methanol, alkyl groups,
t-Butyl alcohol, carbonate and bicarbonate ions, and phosphate ions. The entire reaction
is shown below in Figure 2.x. This reaction is very pH dependent with some of the
previous reactions having differing results in solutions with higher pH (Staehelin &
Hoigne, 1982, p. 677).

The addition of UV radiation to this set of reactions, acting as an AOP, changes the
situation somewhat. UV light is capable of both forming more ozone, by splitting oxygen
molecules in the air and that are given off as a part of the ozone decomposition process,
and hastening the ozone decomposition process and creating more ·OH radicals (Ikemizu
et al., 1987, p. 79). In an aqueous solution, ozone reacts with water in the presence of UV
light to form hydrogen peroxide (H2O2) which can be further disassociated by UV
radiation into 2 ·OH radicals.
𝑂 +𝐻 𝑂
𝐻𝑂

𝐻𝑂

2 · OH
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In addition, UV radiation with wavelengths shorter than 190nm can form hydroxy
radicals directly from water and water vapor (“The Photolysis of Aqueous Systems at
1849 A I. Solutions Containing Nitrous Oxide,” 1965, p. 308; Ung & Back, 1964, p.
754).
Figure 1.8: Reactions of aqueous ozone in presence of solutes M which react with O 3 or
.
OH (Staehelin & Hoigne, 1985, p. 1208)

How much ozone is enough?
An important question to answer when trying to implement a prototype to commercial
use is how efficient is the prototype? The efficiency of estradiol exposure has been
explored previously, specifically how much ozone is required to fully oxidize the
compound, both on its own and in combination with UV radiation. The study (Irmak et
al., 2005, p. 59), which is explored in greater detail in chapter 2, found that using ozone
alone 8.89 mols were required for each mol of estradiol. When UV radiation was
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included, that requirement shrank to 6.64 mols per mol of estradiol. Estradiol has a
molecular weight of 272.4 grams per mol while ozone has a molecular weight of 48
grams per mol. Therefore, in the best-case scenario of complete estradiol oxidation with
the minimum of used ozone, a mass of ozone approximately 15-20 percent more than the
mass of the estradiol would need to be used. In less ideal scenarios, the mass requirement
can approach double the mass of the estradiol to be oxidized.
Hydroxyl Radicals
A hydroxyl radical is composed of a hydrogen atom bonded with an oxygen molecule
and under most atmospheric conditions is the main form of oxidative capacity in the
natural atmosphere (Gligorovski et al., 2015, p. 13079). It is highly reactive due to its
ability to strip hydrogen atoms off other molecules to form water molecules. It can be
formed naturally through solar irradiation of nitrate ions, nitrite ions, and chromophoric
dissolved organic matter (CDOM). Due to this high reactivity, hydroxyl radicals are a
subject of environmental research to remove, transform, or otherwise degrade organic
and inorganic pollutants and contaminants as a part of water and wastewater treatment.
Multiple techniques for forming and using hydroxyl radicals have been implemented
including using hydrogen peroxide, ozone, UV radiation, and /Fe III. The oxidative
capabilities of hydroxyl radicals coupled with their relative ease of production makes
them a key part of any advanced treatment method.
How Ozone and Hydroxyl Radicals act on 17β-Estradiol
The aromatic ring of 17β-Estradiol is susceptible to oxidative action both directly through
action by ozone molecules and indirectly by the ·OH radicals that are formed by ozone
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decomposition. There are two pathways for ozone oxidation of estradiol, but both involve
attacking the aromatic phenol ring and have the same end products of dicarboxylic acids
(Irmak et al., 2005, p. 59). Reactions with ·OH radicals lead to the production of the same
compounds. Intermediate products can be detected using tandem mass spectrometry by
their differing m/z ratios, a ratio of the compounds mass to their charge. These
byproducts differ by where the ozone/ OH radical attached to the aromatic ring of the
estradiol molecule. This difference in position leads to different polarity between
molecules. Regardless, oxidative reactions will begin at the phenolic ring. As this specific
section of its molecular structure is key for proper receptor binding, oxidative reactions to
this structural group should at minimum reduce the possible estrogenic activity of the
compound (Zhao et al., 2008, p. 5283). As exposure continues, more sites along phenolic
ring will be acted on by ·OH radicals in addition to sites along the other aliphatic rings.
These ring rupturing reactions can continue until the only byproducts left are CO 2 and
H2O if exposure continues for a long enough period.
Figure 1.9: Mechanism for direct reaction of ozone with the aromatic ring of estradiol
(Irmak et al., 2005, p. 59)

21

Figure 1.10: Proposed pathway for the formation of the E2 byproduct with m/z 277
(Pereira et al., 2011, p. 1536)
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Chapter 2
Literature Review
In research from Huber et al. (2003, p. 1017), the authors investigated how conventional
ozonation practices and “advanced ozone processes” affected several pharmaceuticals in
a bench-scale environment. The pharmaceuticals in question, Bezafibrate,
Carbamazepine, Diazepam, Diclofenac, 17alpha-Ethinylestradiol, Ibuprofen, Iopromide,
Sulfamethoxazole, and Roxithromycin, were exposed to an ozone stock solution in order
to determine rate constants for their reaction with the ozone, in excess of ozone and in
excess of pharmaceuticals. Rate constants were also found for the compounds’ reaction
with OH radicals. This allowed the authors to create a model predicting the oxidation of
the previously mentioned pharmaceuticals. They then used natural water with varying
dissolved organic carbon content and alkalinity to simulate treatment conditions. Due to
similar molecular features, such as phenol or amino groups, molecules of the same class
are expected to have similar rates of oxidation. The experiment showed that ozone
exposure is extremely effective for reducing concentrations in compounds that are
sensitive to ozone exposure as shown in figure 2.1. Because of their similar structures and
being in the same class of compound, it is expected that 17β-estradiol would be equally
susceptible to ozone oxidation.
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Figure 2.1: Fast-reacting pharmaceuticals percent transformation (Huber et al. 2003)

Deborde et al. showed similar results in their paper (2006, p. 4324). They selected 6
endocrine disruptors, 4-n-nonylphenol (NP), bisphenol A (BPA), 17alphaethinylestradiol, 17β-estradiol, estrone, and estriol due to their increasing occurrence in
the environment. The compounds were dissolved in pure water and exposed to ozone. It
was determined that all of the chosen compounds were highly reactive to ozone, needing
0.002 mg*min/L of exposure to achieve a removal efficiency greater than 95%. They also
exposed the compounds to chlorine to determine how effective the current treatment
process is in removing EDCs. Under the same conditions as the ozone exposure,
chlorination processes required doses orders of magnitude larger than ozone in order to
reach half the starting concentration, 65 mg*min/L for NP, 13 mg*min/L for BPA, and 67 mg*min/L for the hormones. They note that only hormones and BPA could be
efficiently removed, greater than 90%, while ozone was effective for the elimination of
all explored compounds. In addition, they noted that, while still very effective at neutral

24

pH, the ozone oxidation reaction was quite pH dependent for the second-order rate
constants.
Figure 2.2: pH dependence of second-order rate constants for ozone reaction (Deborde
et al., 2005)

In their paper, (Rosenfeldt & Linden, 2004, p. 5479), the authors explored the use of UV
and an advanced oxidation process (AOP) using UV radiation and hydrogen peroxide to
degrade three EDCs: BPA, ethinyl estradiol, and estradiol. They chose compounds due to
their prevalence in the environment and the frequent human exposures that occur. They
note that the combination of UV and hydrogen peroxide can oxidize many organic
compounds found in raw water, including those that cause odors or bad tastes. Therefore,
it could be viable as a tertiary water treatment both to oxidize possible EDC contaminants
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but also to eliminate any remaining organic compounds that could be a problem. The
authors used both monochromatic and polychromatic UV light to evaluate their effect on
the EDCs in addition to adding hydrogen peroxide. Their monochromatic UV lamps
outputted at a wavelength of 253.7 nm. The authors performed their experiment by
exposing solutions spiked with concentrations of the previously mention EDCs with a
UV fluence of 1000 mJ/cm2 by itself for each type of lamp and then again with 15 mg/L
of hydrogen peroxide. In addition, they performed tests to determine the quantum yield
and the hydroxyl radical rate for their experimental design so they could create a model
that could accurately predict EDC destruction in other experiments.

They noted that the compounds absorb UV radiation from wavelengths between 200-300
nm with minimal absorption occurring at approximately 250 nm. The absorption
spectrum of the compounds and the emission spectrum of the two types of UV lamps that
they used are shown in Figure 2.3. The authors note that the monochromatic lamp will
likely do very little to oxidize the compounds due to the compounds absorbing a small
fraction of the radiation from the emitted wavelength.
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Figure 2.3: Absorption and emission spectrum for bisphenol A, ethinyl estradiol,
estradiol, and hydrogen peroxide charted alongside the emission spectrum of the UV
lamps (Rosenfeldt & Linden, 2004, p. 5479).

Figure 2.4: Percent destruction of BPA, EE2, and E2 following UV fluence of 1000
mJ/cm2 via direct photolysis (0 mg/L of H2O2) and UV/ H2O2 AOP (~15 mg/L of H2O2)
(Rosenfeldt & Linden, 2004, p. 5479).
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They were correct with their supposition with the monochromatic lamp oxidizing 5% or
less for all examined compounds. The polychromatic lamp performed better with 14.5%,
21.6%, and 17.7% moving from left to right on Figure 2.4. The inclusion of hydrogen
peroxide drastically improves the degradation, to >90% removal for all compounds, with
only a slight difference between the two types of UV lamps.

The research from Broséus et al. (2009, p. 4710) explored the effect of ozonation on a
number of EDCs, pharmaceuticals and personal care products (PPCPs), and pesticides.
The compounds that were chosen are, caffeine, trimethoprim, carbamazepine, naproxen,
gemfibrozil, estrone, estriol, estradiol, 17α-ethinylestradiol, progesterone,
medroxyprogesterone, norethindrone, levonorgestrel, cyanazine, deethylatrazine, and
deisopropylatrazine. The detection of the compounds was accomplished by automated
on-line solid phase extraction with liquid chromatography and tandem mass spectrometry
to analyze the results. The bench scale experiments were performed with ultrapure water
and filtered water from municipal water treatment plants. Samples were spiked with the
compounds for concentrations in the ng/L range. Ozone was applied in 0 to 3 mg/L doses
via injecting ozone stock solution into a batch continuously stirred glass reactor
containing the water sample. After the dose was given, 4 mL aliquots were taken from
the sample at regular intervals to check for residual ozone concentrations.

The steroid phenolic hormones, estrone, estradiol, ethnylestradiol, showed very high
ozone reaction rate constants when compared to the other compounds, with a k value
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greater than 106 compared to the rest with a range from 558 ± 9 M−1 s−1 to
2215 ± 76 M−1 s−1. The rate constants for natural waters were found to vary by
contaminant, with no significant impact for progesterone up to a 13.5% increase for
northindrone. However, because they were found to be within the same magnitude as the
kinetic rate constants for ultrapure water, the ultrapure water constants were deemed
useful for approximately predicting oxidation in natural waters.

Research by Irmak et al. (2005, p. 59) showed the efficacy of using O 3 and O3/UV
oxidation for the removal of estradiol and BPA. Both compounds were treated in an
aqueous medium at a starting concentration of 0.40 mM. Due to its low solubility in
water, the estradiol solution was prepared by dissolving it in acetonitrile in addition to
water. Acetonitril was used due to miscibility with water and its low reactivity with
ozone. The BPA was dissolved directly into water. An ozone generator was used to
produce ozone which flowed into a glass reactor. Samples were taken from the reactor at
specific intervals and quenched in a mixture of sodium thiosulfate-sodium sulphite
mixture to eliminate residual ozone and OH radicals. The UV lamp used was a 15W lowpressure mercury lamp. The oxidation tests were carried out at different ozone flow rates
to determine its effect.
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Figure 2.5: E2 concentration vs time for different ozone doses (Irmak et al., 2005, p. 59).

As shown in Figure 2.5, the lowest dose of ozone was not sufficient to fully remove the
estradiol concentration. The doses that did fully remove the 0.1 mmol estradiol used
0.868, 0.919, and 0.880 mmol of ozone. As all these amounts are roughly equal, this
shows that the ratio of ozone to estradiol for complete estradiol removal is approximately
8.89 mols of ozone per mol of estradiol oxidized. By applying UV in addition to ozone,
the removal rate is shown to be higher. Of the five ozone doses, four of them completely
oxidized the estradiol by the end of 90 minutes as shown in Figure 2.x. For complete
removal of 0.1 mmol of estradiol, 0.715, 0.672, 0.655, 0.616 mmol of ozone were
consumed for an average of 0.664 mmol. This gives an ozone to estradiol ration of 6.64
mols of ozone per mol of estradiol oxidized, a 22.5% reduction in ozone when UV is also
applied compared to ozone alone.
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Figure 2.6: E2 concentration versus time for different ozone doses during O 3/UV
application (Irmak et al., 2005, p. 59).

Samples taken were run through a HPLC chromatogram and a mass total ion
chromatogram. The MS showed fewer peaks due to its lower sensitivity. The peak
corresponding to estradiol, seen at 23.035 and 22.88 minutes for HPLC and MS
respectively, come after the peaks corresponding to the byproducts.
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Figure 2.7: HPLC chromatogram of ozonation sample of E2 (Irmak et al., 2005, p. 59).

Figure 2.8: Mass total ion chromatogram E2 ozonation sample (Irmak et al., 2005, p. 59)

.
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In research from Snyder et al. (2006, p. 451), the authors performed bench scale and pilot
scale oxidative removal experiments on surface water spiked with target compounds and
on wastewater effluent containing concentrations of target compounds. The authors
targeted several EDCs and pharmaceuticals as a part of their study. For the benchtop
experiments the authors took water samples from Lake Mead and spiked the samples
with the target compounds to achieve concentrations between 100 and 300 ng/L.
calculations were made to determine the dose of ozone required to meet USEPA
regulations on concentration-time, approximately 0.8 min-mg/L for this experiment. 22
of the 36 targeted compounds were removed with an ozone does of 2.5 mg/L. The
percent removal for the remaining compounds are shown in Figure 2.9
Figure 2.9: Bench Scale removal of target compounds that were not removed below level
of detection (Snyder et al., 2006, p. 451)

For the pilot-scale experiments, two testing systems with flow rates of 1.0 L/min and 23
L/min were used to conduct ozone and ozone/hydrogen peroxide oxidation experiments
33

on both wastewater effluent and pretreatment drinking water. The smaller of the two pilot
scale systems, which the authors refer to as Bench-Top Pilot Plant (BTPP), consisted of a
continuous flow ozone contactor, a 208 steel drum acting as a tank, and a peristaltic
pump for controlling flow. Several chemical feed ports were installed to allow for
injection of hydrogen peroxide. BTPP testing was performed with both wastewater and
raw Colorado River water. The 170 L of tertiary treated wastewater that had not been
disinfected. Residual ozone was measure at 2, 6, 10, 14, and 18 minutes. A human breast
carcinoma bioassay was used to measure the estrogenicity of the wastewater experiments.
The results of the bioassay were reported as estradiol equivalents. To evaluate the
production of ·OH radicals, 70L of filtered tertiary treated waste was spiked with probe
compound para-chlorobenzoic acid (pCBA). The residual ozone was determined to have
decayed by the twelve-minute mark for all ozone doses. For the water ozone experiments,
13 of the 36 target compounds had a removal rate greater than 90% within the first two
minutes of zone contact with a dose of 1.25 mg/L. The introduction of hydrogen peroxide
resulted in small increase in removal for most compounds. For a few of the compounds
removal rate was on average 15% lower using ozone and hydrogen peroxide in
combination than with ozone alone. The wastewater contained concentrations of 17 of the
36 target compounds, 7 of which were removed below the level of detection by even the
lowest evaluated dose of ozone of 4.9 mg/L. The bioassay returned significant
estrogenicity for both the raw sewage that was measure and the tertiary treated effluent.
Ozone exposure reduced the estrogenicity to below the level of detection for all ozone
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doses which suggests that the byproducts formed by the oxidative reactions were not
estrogenic in nature.

Phenol is a type of organic compound used in antiseptics, household products, resins,
weed killers, and as an intermediate for industrial synthesis. The term phenol can refer to
the specific compound phenol, or the family of organic compounds that has phenol as the
simplest member (Wade, 2018). Phenols are characterized by a hydroxyl group attached
to an aromatic ring.
Figure 2.10: Depiction of the chemical structure of phenol (National Center for
Biotechnology Information, 2020).

The molecular structure of estradiol bears resemblance to phenol, with an aromatic
carbon ring with an attached hydroxyl group. Because of this structural similarity
research into the oxidative process of phenol could be applicable for the removal and
oxidation of estradiol. Several studies have explored the oxidation of phenol using ozone.
In research from Li et al. (1979, p. 587), the authors showed that ozone rapidly reacted
with the phenol in aqueous solution. The intermediate products were also rapidly
oxidized by the presence of ozone with the final products of the reaction being Catechol,
o-quinone, hydroquinone, oxalic acid, humic acid, and a dimer identified via MS.
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Research by Eisenhaugher (1971, p. 207) sought to improve the efficiency of the phenol
oxidation reaction and to gain a better understanding of the reaction pathway. Using an
ozonation reactor, aqueous solutions of phenol with concentrations ranging from 50 mg/L
to 300 mg/L were exposed to ozone at flow rates of 0.1 L/min to 0.5 L/min. The
experiments were also run at several different pH levels, from 3.00 to 11.06 to observe
how pH affected the reaction. During the experiment the ozone that was not consumed by
the reaction and the carbon dioxide that was released by the reaction was monitored. The
author found that the lower initial pH did not affect the reaction though he noted that the
pH of the system rapidly decreased to a value of 3 to 3.5. At the highest initial pH level
reaction rate nearly doubled while the pH of the system only decreased to a value of 9.9.
The carbon dioxide released by the reaction indicates a complete oxidation of the phenol
in solution and all its oxidative byproducts. The quantity of carbon dioxide if the reaction
was occurring at peak efficiency can be determined by the following stoichiometric
equation.
𝐶 𝐻 𝑂 + 14𝑂 → 6𝐶𝑂 + 3𝐻 𝑂 + 14𝑂
If the reaction was occurring at 100% efficiency, then the conversion of one mole of
phenol into 6 moles of carbon dioxide would require 14 moles of ozone, for 2.33 moles
of ozone per mole of carbon dioxide. As shown in Figure 2.11 below, the efficiency of
the two recorded runs are about 30% and 65%.
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Figure 2.11: carbon dioxide production (Eisenhaugher,1971, p. 207).

At the time, the author was uncertain as to the exact mechanisms that reduced the phenol
to just carbon dioxide. The oxidative pathways were relatively understood up to catechol
and it was assumed that catechol broke down into o-Quinone as shown in Figures 2.12
through 2.14. Later studies into the degradation of phenol would more fully map out the
reaction pathway shown in Figure 2.15.
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Figure 2.12: Formation of intermediate IV by the Baily mechanism (Eisenhaugher,1971,
p. 207).

Figure 2.13: Break down of intermediate IV into catechol (VI) (Eisenhaugher,1971, p.
207).
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Figure 2.14: Degradation of catechol (VI) to o-Quinone (X) (Eisenhaugher,1971, p. 207).

Figure 2.15: Reaction pathway for phenol degradation (Turhan & Uzman, 2008, p. 260).
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Chapter 3
Materials and Methods
For this thesis, there are two portions of the experiment that have materials and
methodology that need to be noted, those being the sample gathering and the testing
portions. Both portions are laid out below.
Ozone Monitor Calibration
In order to accurately measure the ozone in the headspace of the PIOx tank, an ozone
monitor needed to be properly calibrated. To prevent unfortunate circumstances from
hindering accurate measurements, multiple ozone monitors were calibrated for use. The
software to automatically calibrate the monitors was not available so they had to be
calibrated manually. In order to calibrate the monitors, the following items were needed:
ozone monitors, nonreactive tubing, an ozone source, and a computational software such
as Excel. The procedure for calibrating the ozone monitors are as follows. Navigate to the
calibration menus for each monitor and zero out the N and S values. Navigating through
the monitors’ menu, have it output the 1-minute average value. Connect the monitors to
the ozone source via nonreactive tubing in a well-ventilated area. Allow both the ozone
source and the monitors to run for at least an hour before beginning calibration to warm
up. Set the ozone source to output at least 5 different ozone concentrations and record the
value the monitor gave for each concentration. Graph the concentration versus the
recorded value for each monitor. Find the trendline equation for that data set. The
calibration values are calculated from the trendline equation. N is equal to the negative of
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the y intercept of the trendline while S is the inverse of the trendline’s slope. An example
of a calibration spreadsheet is shown below in Figure 3.1.
Figure 3.1: Ozone monitor calibration spreadsheet

Sample Gathering
For the Sample Gathering portion of the experiment, the following materials were used:
PIOx system, Water in excess, Estradiol concentrate, Methanol, Glassware, Pipettor,
Containers for holding samples, ozone monitor. To create the Estradiol concentrate
solution that was used to spike the system, 50 milligrams of powdered Estradiol
concentrate with a purity of >96% was dissolved into 50mL of 200 proof methanol and
enough deionized water to make the total volume 62.5 milliliters. This was done to both
increase the viscosity so a pipettor might be used and to get the concentration to the
intended level of 0.8 milligrams per milliliter.
Two separate methods were used in the taking of sample data. Both methods involved
filling the tank of the PIOx system with approximately 200L of tap water which would be
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spiked with 200 microliters of the Estradiol concentrate for an estimated final
concentration in the tank of 800 picograms per milliliter. The solution would then be
circulated through the tank with the PIOx system active for 15 minutes. The ozone in the
headspace would be measured by the ozone monitor and the value recorded every time a
sample was taken. Where the two methods differ is in when the concentrate would be
applied and the timing of when the samples would be taken.

In the first method, the concentrate would be applied as the machine’s water pump was
on and circulating the water but before the UV light was turned on. The pump was
allowed to circulate the mixture for a few minutes before the 0 minute sample was taken
and the UV lamps were turned on. This was to allow the mixture to be thoroughly mixed
for an accurate starting benchmark before the experiment began. Samples would then be
taken at every odd minute up to the 15-minute mark.

In the second method, the PIOx system would be allowed to run with the UV lamps
activated for several minutes until the peak concentration of ozone in the headspace of
the tank was reached. The concentrate would then be added, along with starting the
timing. Taking a sample at 0 minutes would not be feasible because either the estradiol
concentration would not be mixed into the tank or while waiting for a thoroughly mixed
sample the concentration would be decreasing without being measured. Samples would
then be taken at 1, 3, 5, 7, 11, and 15 minutes. This modification to the methodology was
to simulate a possible application of this piece of technology, that of a water treatment
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plant. In a treatment environment it would be feasible that the system would be running
constantly and therefore this modification would more closely resemble actual service
conditions.
Data Testing
For the Data Testing portion of the experiment, the following materials were used:17βEstradiol high sensitivity ELISA kit Enzo®, Deionized water, Pipettors for volumes
between 5µL and 1,000 µL, Disposable beakers, Glassware, Microplate shaker,
Microplate reader. The Estradiol ELISA kit contains the following items: Assay Buffer
Low BSA, 17β-Estradiol Standard, Donkey anti-Sheep IgG Microtiter Plate, 17βEstradiol Antibody, 17β-Estradiol Conjugate, Wash Buffer concentrate, pNpp Substrate,
Stop Solution, Plate Sealer, Complete Assay Layout Sheet.
ELISA Testing Format
The means of testing the collected samples for this thesis project is via an enzyme linked
immunosorbent assay (ELISA) which is a method that was designed for detecting a
specific protein, peptide, antibody, or biomolecule in a complex solution. The assay
works by preparing the surface of a well plate with antibodies and enzymes that bind to
the substance that is trying to be quantified. The now prepared wells are then washed to
remove anything that was not fixed to the surface before being incubated in a substrate to
allow the reporter enzymes to react. The plate is then read by one of a few different
methods depending on the substrate used to determine the concentration of the subject
compound. This aspect of the process, the binding and immobilization of reagents is what
allows ELISAs to be simple to design and perform. There are a few different methods for
43

how the ELISA works as an assay. The first difference is in how the compound of
interest is attached to the plate. The compound is either attached directly to the surface of
the plate along with any other miscellaneous compounds that are in solution or indirectly
by a capture antibody that is attached to the plate which only will grab the compound of
interest while everything else is washed away. The second difference between these
methods is the means of detection. While the method of attaching the antigen to the well
plate is part of what defines the type of ELISA, the method of detection is largely what
determines the level of sensitivity. Direct detection uses a primary antibody that directly
attaches to the compound of interest and is labeled with a tag or reporter enzyme. Indirect
detection uses a primary antibody that attaches to the antigen along with a secondary
antibody labeled with the reporter enzyme that attaches to the primary antibody. Because
multiple secondary antibodies can attach to the primary antibody, it increases the level of
sensitivity for the assay. There are three different categories of ELISAs based off the
previously mentioned method of capture and detection used. These categories are direct,
indirect, or “sandwich”.

44

Figure 3.2: Diagram of common ELISA formats (Overview of ELISA | Thermo Fisher
Scientific - NL, n.d.)

Direct assays use direct capture and direct detection, indirect assays use direct capture
and indirect detection, and capture or “sandwich” assays use indirect capture and indirect
detection which gives the method its moniker. Because of its sensitivity and reliability,
most commercial ELISA kits utilize the “sandwich” method. There is one other type of
ELISA that these categories do not cover, competitive ELISAs. Competitive ELISAs
utilize indirect capture but differ in how the detection antibodies function. The antibody
that captures the compound of interest can also bind with a conjugate that is added to
each well. The detection enzyme reacts based on the quantity of bound conjugate.
Because there is finite quantity of binding sites in each well, more conjugate bound to the
antibodies means fewer antigens are bound. So, the colorimetric response is inversely
proportional quantity of the compound of interest. The ELISA kit utilized in this thesis
project is a competitive ELISA.
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Figure 3.3: Types of ELISA (Overview of ELISA | Thermo Fisher Scientific - NL, n.d.)
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Assay Preparations
Before the assay procedure, four pieces of preparation need to be accomplished. First, the
reagents need to be allowed to warm to room temperature before use. Second, the wash
buffer that is provided needs to be diluted one part buffer to twenty parts deionized water.
Third, the assay record sheet should be filled out in order to ensure accurate record
keeping and that there are enough wells for all the samples to be analyzed. All samples
should be assayed in duplicate to minimized to effect of any possible contamination or
mistake. An example of the assay record sheet from this experiment will be provided in
the appendix. Finally, the 17β-Estradiol standards by dilution will need to be created.
Figure 3.4: Creation of Estradiol Standards by Dilution (Enzo Life Sciences, 2015)

Allow the 300,000 pg/mL 17β-Estradiol standard to come to room temperature and
vortexed to ensure even concentration. Label seven 12 x 75 m tubes #1 through #7 and
one tube “int”. Pipet 990 µL assay buffer into tube “int” and 800 µL into tube #1. Pipet
500 µL assay buffer into tubes #2 through #7. Remove 10 µL from the stock vial and add
to tube “int” and vortex thoroughly. Remove 400 µL from tube “int” and add to tube #1
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and vortex thoroughly. Remove 500 µL from tube #1 and add to tube #2. Vortex
thoroughly. Continue this from tubes #3 through #7. These diluted standards should be
used in an assay within 60 minutes of preparation. The concentrations of the diluted
standards are shown in Figure 3.1 above.
Assay Procedure
1. Pipet 150 µL of the assay buffer into the NSB (non-specific binding) wells.
2. Pipet 100 µL of the assay buffer into the Bo (0 pg/mL standard) wells.
3. Pipet 100 µL of Standards #1 through #7 to the bottom of the appropriate wells.
4. Pipet 100 µL of the samples to the bottom of the appropriate wells.
5. Pipet 50 µL of the blue conjugate into each well except the TA and Blank wells.
6. Pipet 50 µL of the yellow antibody into each well except the Blank, TA, and NSB
wells. Note: Every well used should be green in color except the NSB wells
which should be blue. The Blank and TA wells are empty at this point and have
no color.
7. Seal the plate. Incubate at room temperature with shaking (~500 rpm) for two
hours.
8. Empty the contents of the wells and wash by adding 400 µL of wash buffer to
every well. Repeat 2 more times for a total of 3 washes. After the final wash,
empty or aspirate the wells and firmly tap the plate on a lint free paper towel to
remove any remaining wash buffer.
9. Pipet 5 µL of the blue conjugate (diluted 1:2) to the TA wells.
10. Add 200 µL of the substrate solution into each well.
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11. Incubate for 1 hour at room temperature without shaking.
12. Pipet 50 µL stop solution into each well.
13. After blanking the plate reader against the substrate blank, read optical density at
405 nm. If plate reader is not capable of adjusting for the blank, manually subtract
the mean OD of the substrate blank from all readings.
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Figure 3.5: Overview of ELISA process for thesis project (Enzo Life Sciences, 2015)
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The data from the plate reader would then be exported in an Excel format which would
be used to make further calculations to ascertain the estradiol concentrations in each
sample. While there is software that is capable of performing the following calculations,
it was unable to be accessed when calculations were being performed.
Evaluating the Raw Data
The results that come from the plate reader are the optical density (OD) of each well in
the plate. The substrate that is added to each well prior to the final incubation is clear at
the start and turns yellow as the enzymes react with the substrate. The amount of signal,
which equates to the darker the color, is inversely proportional to the amount of estradiol
in the sample. However, those results are calculated in relation to the 4 control wells,
Blank, Total Activity (TA), Non-Specific Binding (NSB), and zero standard binding (B 0)
which are laid out in duplicate in the first column as shown on the layout sheet in the
appendix. The blank well, also referred to as a chromogen blank, is filled with only the
substrate and the stop solution. Its purpose is to check the substrate’s contribution to the
OD of the samples, which can be a problem if the substrate is too old. TA wells are
included to act as quality control and check the viability of the conjugate or the coated
antibodies. NSB wells are used in competitive ELISAs to determine the background that
is occurring to unspecific binding of the conjugated enzyme. It is found by not adding the
capture antibody, instead allowing the conjugate to bind directly to the antibodies that
precoated on the plate. It acts as a blank to be subtracted from OD of the samples and can
be useful for determining the source of arbitrarily high results. Finally, the B 0 wells act as
maximum possible value in a competitive ELISA. As only the conjugate and no samples
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are added to the well, the conjugate does not face binding competition so maximum
binding, and therefore maximum coloration, will be achieved. It is typically used in
reference to percent bound (%B or B/B0) where the conjugate binding of each sample is
presented as a percentage of the maximum possible binding (Which Controls to Use in
ELISA Assays?, 2020).

The manual calculation of results begins with averaging the duplicate for each sample
and standard to get the average OD for that sample. Next, the average NSB OD value
should be subtracted from all other average OD values to get the average net OD. This
should remove any background values caused by the substrate. Finally, to find %B for
each value divide average the net OD by the net B 0 OD. By plotting the %B versus
concentration of 17β-Estradiol for the standards a standard curve can be established. The
concentration of 17β-Estradiol of the sample unknowns could then be determined by
interpolation. However, by finding the equation of the trendline and taking the inverse of
it, that inverse equation could be used to directly calculate the concentration of 17βEstradiol using the %B values.

52

Chapter 4
Results and Discussion
A total of 6 sample sets were obtained, an abbreviated initial set meant to ensure that
concentration calculations were correct and that samples would be on the scale set by the
estradiol standards, 3 sets using method one and 2 sets using method two. That truncated
sample set used method one and consisted of only the samples taken at 0, 1, and 15
minutes. The sampling process went swiftly though the ozone monitor was not available
at that time so there is no corresponding data for the ozone concentrations in the
headspace. The ELISA itself was simple enough to complete though time consuming
with the 3 hours of incubation required. In addition, it was noted that performing the
ELISA on such a small number of samples was inefficient. The need to use 22 of the
available 96 wells in the microplate for quality checks and data requirements meant more
waste if the entire plate was not used at once. This was corrected for the later ELISAs.
The standard curve for that run was more than acceptable as shown in Figure 4.1 with an
R2 of 0.9864.
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Figure 4.1: Standard Curve of estradiol concentration versus percent bound for trial run
of experimental procedure.
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As shown in Figure 4.2, all the samples were within the level of detection, so the
estimations that were made for the volume of the tank were reasonable. The initial
concentration is a bit lower than expected at 620 pg/mL rather than the estimated 800
pg/mL but it is within the same order of magnitude with only a 22% difference between
the two values. This could have been due to either a larger quantity of water in the tank
than was estimated or an incomplete mixing which allowed for an area of lower
concentration. Regardless, Figure 4.2 shows a clear downward trend over the 15 minute
testing period with a removal rate of just over 75% at 15 minutes. These results
confirmed previous assumptions as to the capability of the PIOx system for oxidizing
estradiol and confirmed that the starting sample concentrations would be within the level
of detection for the ELISA so the experiment could continue without adjustment.
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Figure 4.2 Estradiol concentrations versus time for trial run
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The first sample set of method one was taken by itself due to time constraints while the
second and third sample sets were performed sequentially on the same day as the sample
sets for method two. The ozone readings for that day of testing shown in figure 4.x
indicated a decrease in ozone concentrations in the headspace. This decline in
concentrations was later quantified The ELISA standards that were run alongside the
samples showed good results with R2 values equal to 0.9669 and 0.9971 respectively.
To determine the estradiol concentrations for the samples, the inverse of the Standard
curve is needed, as mentioned in the previous chapter. This allows the value for percent
bound to be plugged into the trendline equation to get its equivalent estradiol
concentration. Finding the inverse of Figures 4.3 & 4.4 yields Figures 4.5 & 4.6. The
trendlines of those figures then were used to calculate the concentrations of estradiol for
all the sample sets.
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Figure 4.3: Estradiol concentration versus percent bound for set 1 of method one
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Figure 4.4: Estradiol concentration vs percent bound for sets 2 & 3 for method 1 and all
sets for method 2.
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Figure 4.5: Inverse of Figure 4.3 for calculation of estradiol concentration in samples
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Figure 4.6: Inverse of Figure 4.4 for calculation of estradiol concentration in samples
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Figure 4.7: Estradiol concentration versus time for first sample set of method 1
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Figure 4.8: Estradiol concentration versus time for second sample set of method 1
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Figures 4.9: Estradiol concentration versus time for third run of method 1
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Figure 4.10: Average percent reduction of experimental method 1
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The starting concentrations varied significantly between all three runs despite allowing
for more than adequate mixing. This variation indicates an error either in the measuring
of the concentrate for spiking the tank, in the creation of the concentrate, or in the filling
of the tank with water. The sample sets are still able to be aggregated into a single result
using percent reduction, but it does indicate a need for more precise measurement. All 3
sample sets had concentrations below the level of detection for the ELISA, at 14 pg/mL
by 15 minutes. This is a significant improvement in removal efficacy over what was
suggested by the trial run. Figure 4.10 has significant variation for the first several data
points with the error bars shrinking as time continues. The deviation from the trend line
may be due to incomplete mixing leading to pockets of higher or lower concentrations. It
may also be due to how exactly the samples were collected, either taking the sample
immediately or by allowing the possibly stagnant and unmixing water pooling in the
spigot to run out for a few seconds before taking the sample.
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Ozone readings were recorded from the ozone monitor connected to the headspace for
every sample that was taken for the second and third sample sets of method one and for
all sample sets of method two. The recorded ozone readings are shown in Figure 4.11.
The readings show a clear downward trend over time which was not immediately
explainable. In order to ascertain if the decline in concentration was due to the oxidative
reactions taking place or due to some other source, a series three runs of the PIOx system
without estradiol were completed. These dry runs were held for a total of one hour with
ozone readings taken at 0, 1, 2, 3, 4, 5 minutes and every fifth minute after that. The
results of those three dry runs are shown in Figures 4.12 & 4.13.
Figure 4.11: Ozone in headspace
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Figure 4.12: Dry run ozone readings

Figure 4.13: Percent of maximum ozone remaining
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Figure 4.14: Estradiol concentration versus time for first sample set of method 2
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Figure 4.15: Estradiol concentration versus time for second sample set of method 2
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Figures 4.16: Average percent reduction versus time for experimental method 2
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The method two samples were less successful, with significantly more deviation from the
trend. Only one of the two runs achieved concentrations below level of detection within
the 15-minute testing time. This is almost certainly an effect of the lack of time given to
ensure homogeneous concentrations leading to pockets of higher estradiol concentrations.
This could be alleviated by increasing the length of exposure to ensure elimination.

The viability of the PIOx system can only be measure when compared to other studies
and systems. The study by Irmak et al. (2005, p. 59) carried out similar oxidation
experiments on estradiol using a combination of UV and ozone exposure. As noted
previously the authors exposed 0.1 mmol of estradiol, equivalent to 27.24 mg, to several
ozone flow rates from 15.89x10-3 mmol/min to 7.56x10-3 mmol/min. For the ozone/UV
process this consumed 0.664 mmol of ozone, equivalent to 31.872 mg, to completely
eliminate the estradiol concentration. This led to an “efficiency” of 6.64 moles of ozone
required to consume 1 mole of estradiol. While the circumstances for this project were
less controlled than theirs, owing to the inability to precisely gauge ozone production, it
is still a reasonable comparison. For these experiments, 200 µg of the concentrate, which
had a concentration of 0.8 mg/mL, was used to spike the system before each test. This
equates to 0.16 mg of estradiol or 5.9x10-4 mmol in the system. The one hour dry run of
the system showed an ozone concentration from 160,000 ppb to 80,000 ppb. The ozone
monitor samples directly from where the UV lamps are situated so it can be assumed that
the volume for that concentration is localized around the lamps as well. The contact
chamber around the lamps has a volume of approximately 134 in 3 or 2.2x10-3 m3.
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Converting from ppb to mg/m3 and then multiplying by the chamber volume gives a total
production over one hour of 8.77 mg of ozone and a production rate of 0.146 mg/min or
3.0x10-3 mmol/min. Over the 15 minute testing period, the samples would be exposed to
4.56x10-2 mmol of ozone. If all of the produced ozone reacted with the estradiol, this
would give an ozone/estradiol ratio of 77.29. The calculations are shown below in Figure
4.17.
Figure 4.17: Spreadsheet calculations of PIOx ozone production

This ratio is significantly higher than the ratio obtained by the authors and even further
away from the theoretical minimum ratio. The most likely reason for the discrepancy is
the lack of precise dosages, the inability to determine how much of the ozone goes
unreacted due to the system constantly producing more ozone. The ozone production rate
is an underestimation as ozone concentrations in the water were unable to be accurately
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measured by ad hoc colorimetric tests. In addition, the ozone could diffuse into the
headspace of the main tank which could partially explain the consistent decline in ozone
concentrations during the tests.

There are a few different ways this set of experiments could be improved which could
also lead to improved efficiencies for the PIOx system. A secondary ozone monitor
drawing samples from the headspace of tank after the contact chamber could be installed
as a means of possibly determining the quantity of unreacted ozone. This would hinder
the system’s ability to run with a completely full tank but would aid in accurately
measuring important metrics.

A carbon dioxide monitor could also be installed as another metric of estradiol
elimination. In addition, a carbon dioxide monitor would give an indication as to the
extent of the degradation of the intermediate products. As shown by (Eisenhaugher,1971,
p. 207), the oxidative process of phenol has carbon dioxide as a byproduct at several
steps from the rupturing of aromatic ring and the stripping of the carbon atoms from its
structure. As estradiol has a phenolic group, it is reasonable to assume that the oxidation
of estradiol would lead to carbon dioxide also being a byproduct.

A final improvement to the system could be the inclusion of a polychromatic medium
pressure UV lamp rather than the predominantly monochromatic UV lamp that is
currently a part of the PIOx system. As shown previously in research by (Rosenfeldt &
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Linden, 2004, p. 5479), a polychromatic UV lamp would allow for significantly more
oxidation by direct photolysis due to the increased emission band allowing for more
absorption and an increase in ozone production if the wavelength is in the 100-200nm
range.
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Chapter 5
Conclusions and Recommendations
The PIOx system proved to be quite effective in the idealized scenario of the Method one
with removal below level of detection within 15 minutes. However, Method two shows
that the system has some difficulties handling the sudden introduction of contaminants
similar to that of a treatment environment with full reduction not occurring within the 15minute testing window. When compared to other similar oxidative processes, PIOx is less
efficient requiring more ozone to oxidize estradiol though that can be partially explained
by the inability to accurately measure unreacted ozone. Overall the system is capable of
eliminating estradiol at concentrations equivalent to environmental concentrations within
a reasonable timeframe. It is reasonable to assume that it would be equally capable in
oxidizing other ozone sensitive compounds in a similar manner.

The system could be improved by installing a carbon dioxide monitor and an additional
ozone monitor to allow for observation of waste ozone and byproducts of the oxidative
process. Because the PIOx system functions as continuous flow stirred tank reactor when
operating in its original capacity, it could be implemented in a similar manner in a water
or wastewater treatment plant as a tertiary treatment. Proper installation of the system
could allow for longer exposure periods which would increase the likelihood of
completely eliminating estradiol and other EDCs.
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One significant hurdle that will need to be overcome to allow for widescale
implementation of the PIOx system and other AOPs is the expense both in time and costs
for testing contaminant concentrations. To accurately measure the concentration of
estradiol specifically or EDCs in general, either an assay for each contaminant would
need to be purchased, which would be costly and tedious, or a detection technique like
HPLC or MS would need to employed which requires expensive equipment. Water and
wastewater treatment plants run multiple tests on a daily basis to ensure the contaminant
standards are being met and that any unusual spikes of regulated contaminants can be
compensated for. If EDCs are to be included in that list of regulated compounds, then
quicker and less expensive detection methods need to be explored to ensure that
standards can be met.
The heart of the PIOx system is just the UV bulbs and the sleeve to create the micron
foam. Therefore, scaling the system is just a matter of more UV bulbs, larger or more
numerous sleeves, and higher capacity pumps that are capable of outputting at the
required pressure to maintain the microfoam. There are other considerations that need to
be explored before commercial implementation. How the size of any dissolved solids in
solution may affect the design life of the PIOx system needs further exploration, in
addition to how the bulbs’ capability degrades under commercial conditions.
Maintenance protocols for cleaning the metal screen would need to be established in
addition to exploring how the system design could be modified to expedite the
refurbishment or replacement of the screen and bulbs.
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Further research is needed to determine what other EDCs the PIOx system is capable of
removing. PIOx is behaving similarly to other UV/O3 AOPs but tests should be
conducted using other EDCs to determine the capabilities of the system and where its
limits are. Should the system maintain its similarity to other AOPs, PIOx could have the
largest impact in more rural settings and smaller communities due to its more modular
nature. Small scale applications would require minimal resizing allowing relative ease in
set up.

There are other assays and methods of detection that provide near real-time results. These
methods, which include an immuno-polymerase chain reaction and the use of estradiol
imprinted nanoparticles and atomic force microscopy, are the subjects of research papers
and are not commercially available. Reaching out to the authors of these projects would
be useful to the continued exploration and application of the PIOx system to wastewater
and water treatment.

69

References
Auriol, M., Filali-Meknassi, Y., Tyagi, R. D., Adams, C. D., & Surampalli, R. Y. (2006).
Endocrine disrupting compounds removal from wastewater, a new challenge.
Process Biochemistry, 41(3), 525–539.
https://doi.org/10.1016/j.procbio.2005.09.017
B. (n.d.). What is ELISA? - An Introduction to ELISA. Bio-Rad. https://www.bio-radantibodies.com/an-introduction-to-elisa.html
Broséus, R., Vincent, S., Aboulfadl, K., Daneshvar, A., Sauvé, S., Barbeau, B., &
Prévost, M. (2009). Ozone oxidation of pharmaceuticals, endocrine disruptors and
pesticides during drinking water treatment. Water Research, 43(18), 4707–4717.
https://doi.org/10.1016/j.watres.2009.07.031
Deborde, M., Rabouan, S., Duguet, J.-P., & Legube, B. (2006). Kinetics of Aqueous
Ozone-Induced Oxidation of Some Endocrine Disruptors. Environmental Science
& Technology, 40(13), 4324. https://doi.org/10.1021/es068007p
Eisenhaugher, H. R. (1971). Increased Rate and Efficiency of Phenolic Waste
Ozonization. Water Pollution Control Federation, 43(2), 200–208.
https://www.jstor.org/stable/25036886
Endocrine Disruptors. (2020). National Institute of Environmental Health Sciences.
https://www.niehs.nih.gov/health/topics/agents/endocrine/index.cfm
Enzo Life Sciences. (2015, January). 17β-Estradiol high sensitivity ELISA kit.
https://www.enzolifesciences.com/fileadmin/files/manual/ADI-900174_insert.pdf
Futran Fuhrman, V., Tal, A., & Arnon, S. (2015). Why endocrine disrupting chemicals
(EDCs) challenge traditional risk assessment and how to respond. Journal of
Hazardous Materials, 286, 589–611.
https://doi.org/10.1016/j.jhazmat.2014.12.012
Gaudet, D., Nilsson, D., Lohr, T. & Sheedy, C. (2015). Development of a real-time
immuno-PCR assay for the quantification of 17β-estradiol in water, Journal of
Environmental Science and Health, Part B, 50:10, 683-690, DOI:
10.1080/03601234.2015.1048097
Glaze, W. H., Kang, J.-W., & Chapin, D. H. (1987). The Chemistry of Water Treatment
Processes Involving Ozone, Hydrogen Peroxide and Ultraviolet Radiation. Ozone:

70

Science & Engineering, 9(4), 335–352.
https://doi.org/10.1080/01919518708552148
Gligorovski, S., Strekowski, R., Barbati, S., & Vione, D. (2015). Environmental
Implications of Hydroxyl Radicals (•OH). Chemical Reviews, 115(24), 13051–
13092. https://doi.org/10.1021/cr500310b
Gore, A. C., Chappell, V. A., Fenton, S. E., Flaws, J. A., Nadal, A., Prins, G. S., Toppari,
J., & Zoeller, R. T. (2015). EDC-2: The Endocrine Society’s Second Scientific
Statement on Endocrine-Disrupting Chemicals. Endocrine Reviews, 36(6), E1–
E150. https://doi.org/10.1210/er.2015-1010
Houtman, C. J., Kroesbergen, J., Lekkerkerker-Teunissen, K., & van der Hoek, J. P.
(2014). Human health risk assessment of the mixture of pharmaceuticals in Dutch
drinking water and its sources based on frequent monitoring data. Science of The
Total Environment, 496, 54–62. https://doi.org/10.1016/j.scitotenv.2014.07.022
Huang, Y.-W., Phillips, J. R., & Hunter, L. D. (2007). Human exposure to medicinal,
dietary, and environmental estrogens. Toxicological & Environmental Chemistry,
89(1), 141–160. https://doi.org/10.1080/02772240600952141
Huber, M. M., Canonica, S., Park, G.-Y., & von Gunten, U. (2003). Oxidation of
Pharmaceuticals during Ozonation and Advanced Oxidation Processes.
Environmental Science & Technology, 37(5), 1016–1024.
https://doi.org/10.1021/es025896h
Ikehata, K., Gamal El-Din, M., & Snyder, S. A. (2008). Ozonation and Advanced
Oxidation Treatment of Emerging Organic Pollutants in Water and Wastewater.
Ozone: Science & Engineering, 30(1), 21–26.
https://doi.org/10.1080/01919510701728970
Ikemizu, Kiyoshi, Morooka, Shigeharu, & Kato, Yasuo (1987). Decomposition rate of
ozone in water with ultraviolet radiation. Journal of Chemical Engineering of
Japan, 20(1), 77–81. https://doi.org/10.1252/jcej.20.77
Irmak, S., Erbatur, O., & Akgerman, A. (2005). Degradation of 17β-estradiol and
bisphenol A in aqueous medium by using ozone and ozone/UV techniques.
Journal of Hazardous Materials, 126(1–3), 54–62.
https://doi.org/10.1016/j.jhazmat.2005.05.045
Jönsson, B. A. G., Faniband, M., & Lindh, C. H. (2014). Human biological monitoring of
suspected endocrine-disrupting compounds. Asian Journal of Andrology, 16(1), 5.
https://doi.org/10.4103/1008-682x.122197

71

Lee, S., Jeong, W., Kannan, K., & Moon, H.-B. (2016). Occurrence and exposure
assessment of organophosphate flame retardants (OPFRs) through the
consumption of drinking water in Korea. Water Research, 103, 182–188.
https://doi.org/10.1016/j.watres.2016.07.034
Leung, H. W., Jin, L., Wei, S., Tsui, M. M. P., Zhou, B., Jiao, L., Cheung, P. C., Chun,
Y. K., Murphy, M. B., & Lam, P. K. S. (2013). Pharmaceuticals in Tap Water:
Human Health Risk Assessment and Proposed Monitoring Framework in China.
Environmental Health Perspectives, 121(7), 839–846.
https://doi.org/10.1289/ehp.1206244
Li, K. Y., Kuo, C. H., & Weeks, J. L. (1979). A kinetic study of ozone-phenol reaction in
aqueous solutions. AIChE Journal, 25(4), 583–591.
https://doi.org/10.1002/aic.690250403
Mallozzi, M., Leone, C., Manurita, F., Bellati, F., & Caserta, D. (2017). Endocrine
Disrupting Chemicals and Endometrial Cancer: An Overview of Recent
Laboratory Evidence and Epidemiological Studies. International Journal of
Environmental Research and Public Health, 14(3), 334.
https://doi.org/10.3390/ijerph14030334
MohanKumar, S. M. J., Balasubramanian, P., Subramanian, M., & MohanKumar, P. S.
(2018). Chronic estradiol exposure – harmful effects on behavior, cardiovascular
and reproductive functions. Reproduction, R169–R186.
https://doi.org/10.1530/rep-18-0116
National Center for Biotechnology Information. (2020). Phenol. PubChem.
https://pubchem.ncbi.nlm.nih.gov/compound/Phenol
OSH Answers Fact Sheets. (2020, November 4). Canadian Centre for Occupational
Health and Safety.
https://www.ccohs.ca/oshanswers/hsprograms/risk_assessment.html#:%7E:text=R
isk%20assessment%20is%20a%20term,analysis%2C%20and%20risk%20evaluati
on).
Overview of ELISA | Thermo Fisher Scientific - NL. (n.d.). Overview of ELISA.
https://www.thermofisher.com/nl/en/home/life-science/protein-biology/proteinbiology-learning-center/protein-biology-resource-library/pierce-proteinmethods/overview-elisa.html
Ozone. (1999, July 30). NASA Earth Observatory.
https://earthobservatory.nasa.gov/features/Ozone/ozone_2.php#:%7E:text=In%20
the%20stratosphere%2C%20ozone%20is,form%20a%20molecule%20of%20ozo
ne.
72

Ozone reaction mechanisms. (2003). Lenntech.
https://www.lenntech.com/library/ozone/reaction/ozone-reactionmechanisms.htm#:%7E:text=Summarized%2C%20ozone%20oxidizes%20organi
c%20compounds,are%20oxidized%20fast%20and%20completely.&text=During
%20the%20last%20reaction%2C%20HO,again%20(see%20reaction%202).
Pereira, R. O., de Alda, M. L., Joglar, J., Daniel, L. A., & Barceló, D. (2011).
Identification of new ozonation disinfection byproducts of 17β-estradiol and
estrone in water. Chemosphere, 84(11), 1535–1541.
https://doi.org/10.1016/j.chemosphere.2011.05.058
Prins, G. S. (2008). Endocrine disruptors and prostate cancer risk. Endocrine Related
Cancer, 15(3), 649–656. https://doi.org/10.1677/erc-08-0043
Rachoń, D. (2015). Endocrine disrupting chemicals (EDCs) and female cancer:
Informing the patients. Reviews in Endocrine and Metabolic Disorders, 16(4),
359–364. https://doi.org/10.1007/s11154-016-9332-9
Rexroad, C. E. (1977). Plasma estradiol-17β concentration in ewes and cows after
estradiol-17β administration. Theriogenology, 8(2–3), 83–91.
https://doi.org/10.1016/0093-691x(77)90225-4
Rosa Boleda, M., Huerta-Fontela, M., Ventura, F., & Galceran, M. T. (2011). Evaluation
of the presence of drugs of abuse in tap waters. Chemosphere, 84(11), 1601–1607.
https://doi.org/10.1016/j.chemosphere.2011.05.033
Rosenfeldt, E. J., & Linden, K. G. (2004). Degradation of Endocrine Disrupting
Chemicals Bisphenol A, Ethinyl Estradiol, and Estradiol during UV Photolysis
and Advanced Oxidation Processes. Environmental Science & Technology,
38(20), 5476–5483. https://doi.org/10.1021/es035413p
Schug, T. T., Johnson, A. F., Birnbaum, L. S., Colborn, T., Guillette, L. J., Crews, D. P.,
Collins, T., Soto, A. M., vom Saal, F. S., McLachlan, J. A., Sonnenschein, C., &
Heindel, J. J. (2016). Minireview: Endocrine Disruptors: Past Lessons and Future
Directions. Molecular Endocrinology, 30(8), 833–847.
https://doi.org/10.1210/me.2016-1096
Snyder, S. A., Wert, E. C., Rexing, D. J., Zegers, R. E., & Drury, D. D. (2006). Ozone
Oxidation of Endocrine Disruptors and Pharmaceuticals in Surface Water and

73

Wastewater. Ozone: Science & Engineering, 28(6), 445–460.
https://doi.org/10.1080/01919510601039726
Staehelin, J., & Hoigne, J. (1982). Decomposition of ozone in water: rate of initiation by
hydroxide ions and hydrogen peroxide. Environmental Science & Technology,
16(10), 676–681. https://doi.org/10.1021/es00104a009
Staehelin, J., & Hoigne, J. (1985). Decomposition of ozone in water in the presence of
organic solutes acting as promoters and inhibitors of radical chain reactions.
Environmental Science & Technology, 19(12), 1206–1213.
https://doi.org/10.1021/es00142a012
Street, M., Angelini, S., Bernasconi, S., Burgio, E., Cassio, A., Catellani, C., Cirillo, F.,
Deodati, A., Fabbrizi, E., Fanos, V., Gargano, G., Grossi, E., Iughetti, L.,
Lazzeroni, P., Mantovani, A., Migliore, L., Palanza, P., Panzica, G., Papini, A., …
Amarri, S. (2018). Current Knowledge on Endocrine Disrupting Chemicals
(EDCs) from Animal Biology to Humans, from Pregnancy to Adulthood:
Highlights from a National Italian Meeting. International Journal of Molecular
Sciences, 19(6), 1647. https://doi.org/10.3390/ijms19061647
The photolysis of aqueous systems at 1849 A I. Solutions containing nitrous oxide.
(1965). Proceedings of the Royal Society of London. Series A. Mathematical and
Physical Sciences, 287(1410), 295–311. https://doi.org/10.1098/rspa.1965.0181
The Serotonin Molecule. (2006). World of Molecules.
https://www.worldofmolecules.com/emotions/estrogen.htm#:%7E:text=Estrogen
%20Molecules,in%20terms%20of%20estrogenic%20activity.
Turhan, K., & Uzman, S. (2008). Removal of phenol from water using ozone.
Desalination, 229(1–3), 257–263. https://doi.org/10.1016/j.desal.2007.09.012
Ung, A. Y.-M., & Back, R. A. (1964). The Photolysis of Water Vapor and Reactions of
Hydroxyl Radicals. Canadian Journal of Chemistry, 42(4), 753–763.
https://doi.org/10.1139/v64-114
U.S. Department of Health and Human Services. (2007, March). Sunnyside Area
Groundwater Contamination.
https://www.atsdr.cdc.gov/hac/pha/SunnysideAreaGroundwaterContamination/Su
nnysideAreaGroundwaterHC031907.pdf
Wade, L. G. (2018). phenol | Definition, Structure, Uses, & Facts. Encyclopedia
Britannica. https://www.britannica.com/science/phenol

74

Wee, S. Y., & Aris, A. Z. (2017). Endocrine disrupting compounds in drinking water
supply system and human health risk implication. Environment International,
106, 207–233. https://doi.org/10.1016/j.envint.2017.05.004
Wee, S. Y., & Aris, A. Z. (2019). Occurrence and public-perceived risk of endocrine
disrupting compounds in drinking water. Npj Clean Water, 2(1), 1.
https://doi.org/10.1038/s41545-018-0029-3
Which Controls to Use in ELISA Assays? (2020, September 25). Enzo Life Sciences.
https://www.enzolifesciences.com/sciencecenter/technotes/2019/november/which-controls-to-use-in-elisa-assays?/
Yang, G. C. C., Yen, C.-H., & Wang, C.-L. (2014). Monitoring and removal of residual
phthalate esters and pharmaceuticals in the drinking water of Kaohsiung City,
Taiwan. Journal of Hazardous Materials, 277, 53–61.
https://doi.org/10.1016/j.jhazmat.2014.03.005
Zhao, Y., Hu, J., & Jin, W. (2008). Transformation of Oxidation Products and Reduction
of Estrogenic Activity of 17β-Estradiol by a Heterogeneous Photo-Fenton
Reaction. Environmental Science & Technology, 42(14), 5277–5284.
https://doi.org/10.1021/es703253q
Zhao, Y., Huang, M., Ge, M., Tang, X., & Liu, L. (2010). Influence factor of 17βestradiolphotodegradation by heterogeneous Fenton reaction. J. Environ. Monit.,
12(1), 271–279. https://doi.org/10.1039/b907804e
Zoeller, R. T., Brown, T. R., Doan, L. L., Gore, A. C., Skakkebaek, N. E., Soto, A. M.,
Woodruff, T. J., & Vom Saal, F. S. (2012). Endocrine-Disrupting Chemicals and
Public Health Protection: A Statement of Principles from The Endocrine Society.
Endocrinology, 153(9), 4097–4110. https://doi.org/10.1210/en.2012-1422

75

Appendix A. Plate Layout Sheet for ELISA Kit

76

